Caplin Point has set up a dedicated pharmaceutical R&D facility with capabilities to develop safe and effective formulations. Sophisticated facilities and resources are available to develop dosage forms like Tablets, Capsules, Semi-solids (including suppositories) and Liquid orals. The R & D is having separate teams for formulation development and analytical development. R & D scale stability studies, forced degradation studies, method development and validations are carried out in house. The Caplin R & D can provide the following range of services:

• Development of new formulations in oral solid dosage forms and external preparations segments
• Design and development of new dosage forms as per customer needs
• Process improvements and optimization
• Stability studies as per ICH guidelines
• Analytical development and Method validations as per ICH
• Technology transfer of new developed formulations
• Dissolution profiles as per CDER/EU guidelines